Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1985-07-25
1986-11-11
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 88, 530326, 530327, 530328, A61K 39095, C07K 706, C07K 708
Patent
active
046222235
ABSTRACT:
Vaccines comprising peptide sequences corresponding to immunorecessive determinants in gonorrhea pilus protein are disclosed. The vaccines are effective in protecting human subjects against infection by a wide range of gonorrhea strains by raising antibodies which interfere with the colonization of the epithelium by the infecting bacteria or which enhance phagocytosis.
REFERENCES:
patent: 4443431 (1984-04-01), Buchanan et al.
Chemical Abstracts, vol. 98, Abstract No. 213829n, 1983.
Chemical Abstracts, vol. 101, Abstract No. 125160n, 1984.
Rothbard Jonathan
Schoolnik Gary K.
Hazel Blondel
The Board of Trustees for the Leland Stanford University
LandOfFree
Broad spectrum vaccine against gonorrhea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Broad spectrum vaccine against gonorrhea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Broad spectrum vaccine against gonorrhea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-376565